IMMUCELL CORP's ticker is ICCC and the CUSIP is 452525306. A total of 21 filers reported holding IMMUCELL CORP in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $144,000 | +111.8% | 19,475 | +69.7% | 0.04% | +111.1% |
| Q3 2015 | $68,000 | -56.1% | 11,475 | -41.8% | 0.02% | -37.9% |
| Q2 2015 | $155,000 | -6.6% | 19,704 | -25.3% | 0.03% | 0.0% |
| Q1 2015 | $166,000 | -2.9% | 26,367 | -23.5% | 0.03% | +7.4% |
| Q4 2014 | $171,000 | 0.0% | 34,467 | 0.0% | 0.03% | +22.7% |
| Q3 2014 | $171,000 | +12.5% | 34,467 | 0.0% | 0.02% | +37.5% |
| Q2 2014 | $152,000 | +4.1% | 34,467 | +13.1% | 0.02% | -5.9% |
| Q1 2014 | $146,000 | +12.3% | 30,467 | 0.0% | 0.02% | +6.2% |
| Q4 2013 | $130,000 | -12.2% | 30,467 | -2.6% | 0.02% | -33.3% |
| Q3 2013 | $148,000 | – | 31,293 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Financial Services, Inc. | 23,776 | $89,000 | 0.03% |
| SHUFRO ROSE & CO LLC | 51,263 | $192,000 | 0.02% |
| Tower Research Capital LLC (TRC) | 254 | $1,000 | 0.00% |
| Creative Planning | 310 | $1,000 | 0.00% |
| Renaissance Technologies | 10,000 | $38,000 | 0.00% |
| UBS AG | 1,870 | $7,000 | 0.00% |
| US BANCORP \DE\ | 24 | $0 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 2,032 | $8,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1 | $0 | 0.00% |
| MORGAN STANLEY | 29,628 | $111,000 | 0.00% |